Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endless education

R Salzberg, M Just

    JAMA
    |June 24, 1988
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    First-line ET plus palbociclib versus standard mono-chemotherapy in high-risk HR-positive/HER2-negative metastatic breast cancer and indication for chemotherapy: primary results from the randomized phase IV PADMA study.

    ESMO open·2026
    Same author

    Clinical and molecular biomarkers for prediction of endocrine response after short preoperative endocrine therapy in the WSG ADAPT-HR+/HER2- and ADAPTcycle trials (N = 7914).

    Annals of oncology : official journal of the European Society for Medical Oncology·2026
    Same author

    Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX).

    ESMO open·2025
    Same author

    Long-term outcome data for patients with hormone receptor-positive early breast cancer participating in the WSG PlanB trial after preselection by gene expression analysis: 10-year survival results from the WSG PlanB registry.

    ESMO open·2025
    Same author

    Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292).

    ESMO open·2025
    Same author

    Prediction of survival after de-escalated neoadjuvant therapy in HER2-positive early breast cancer: a pooled analysis of three WSG trials.

    Annals of oncology : official journal of the European Society for Medical Oncology·2025
    Same journal

    Deescalation, Discontinuation, and Deimplementation Trials: Evaluating Whether and How to Do Less.

    JAMA·2026
    Same journal

    Surgical and Endoscopic Therapies for GERD.

    JAMA·2026
    Same journal

    The Psychedelic Therapies Executive Order: On Approval and Clinical Readiness.

    JAMA·2026
    Same journal

    "Suturing": Love, Death, and Perfection's Limits.

    JAMA·2026
    Same journal

    What Is Low Back Pain?

    JAMA·2026
    Same journal

    From Silicon Valley to the Vatican-The Expanding Debate on AI Ethics.

    JAMA·2026
    See all related articles